These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23546513)

  • 1. Controlled release of human growth hormone fused with a human hybrid Fc fragment through a nanoporous polymer membrane.
    Kim ES; Jang DS; Yang SY; Lee MN; Jin KS; Cha HJ; Kim JK; Sung YC; Choi KY
    Nanoscale; 2013 May; 5(10):4262-9. PubMed ID: 23546513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells.
    Lee JH; Yeo J; Park HS; Sung G; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
    Protein Expr Purif; 2013 Jan; 87(1):17-26. PubMed ID: 23009882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural form of noncytolytic flexible human Fc as a long-acting carrier of agonistic ligand, erythropoietin.
    Im SJ; Yang SI; Yang SH; Choi DH; Choi SY; Kim HS; Jang DS; Jin KS; Chung YK; Kim SH; Paik SH; Park YC; Chung MK; Kim YB; Han KH; Choi KY; Sung YC
    PLoS One; 2011; 6(9):e24574. PubMed ID: 21957455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical evaluation of hybrid Fc fusion protein of hGH to achieve basal buffer system.
    Kim NA; An IB; Lim HS; Yang SI; Jeong SH
    Int J Pharm; 2016 Nov; 513(1-2):421-430. PubMed ID: 27659863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacology study of a new recombinant TNF receptor-hyFc fusion protein.
    Lee JH; Cho JH; Yeo J; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
    Biologicals; 2013 Mar; 41(2):77-83. PubMed ID: 23190454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-acting erythropoietin fused with noncytolytic human Fc for the treatment of anemia.
    Yang SH; Yang SI; Chung YK
    Arch Pharm Res; 2012 May; 35(5):757-9. PubMed ID: 22644842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and characterization of human growth hormone-Fc fusion proteins for transcytosis induction.
    Lee CH; Woo JH; Cho KK; Kang SH; Kang SK; Choi YJ
    Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):211-7. PubMed ID: 17067288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of human IL-35-IgG4 (Fc) fusion protein in CHO/DG44 cells].
    Tang J; Gao W; Zhang Q; Zhang D; Chen Y; He B; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):109-15. PubMed ID: 19441235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles.
    Rafi M; Singh SM; Kanchan V; Anish CK; Panda AK
    J Microencapsul; 2010; 27(6):552-60. PubMed ID: 20690791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal alanine-extended GLP-1/IgG-Fc fusion protein confers resistance to DPP-IV and reduces serum glucose level in db/db mice.
    Chung HS; Oh JY; Yoo SB; Lee SM; Cho HS
    Regul Pept; 2011 Oct; 170(1-3):1-3. PubMed ID: 21621561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single chain Fc-dimer-human growth hormone fusion protein for improved drug delivery.
    Zhou L; Wang HY; Tong S; Okamoto CT; Shen WC; Zaro JL
    Biomaterials; 2017 Feb; 117():24-31. PubMed ID: 27923197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS.
    Cao P; Zhang S; Fang Z; Huang H; Bai P; Zhang Q; Luo C
    Appl Microbiol Biotechnol; 2008 Feb; 78(2):275-82. PubMed ID: 18189138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLP-1-Exendin-4/IgG4 (Fc) fusion protein as a novel drug for diabetes treatment.
    Gan Y; Dang N; Qu Z; Shi R; Ding L; Wang L; Pang S
    Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):371-5. PubMed ID: 25962403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone.
    Yao W; Yu L; Fan W; Shi X; Liu L; Li Y; Qin X; Rao C; Wang J
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30970583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal delivery of hyaluronic acid -- human growth hormone conjugate.
    Yang JA; Kim ES; Kwon JH; Kim H; Shin JH; Yun SH; Choi KY; Hahn SK
    Biomaterials; 2012 Sep; 33(25):5947-54. PubMed ID: 22632765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of recombinant rhesus macaque IL-10/Fc(ala-ala) fusion protein: a potential adjunct for tolerance induction strategies.
    Asiedu C; Guarcello V; Deckard L; Jargal U; Gansuvd B; Acosta EP; Thomas JM
    Cytokine; 2007 Dec; 40(3):183-92. PubMed ID: 17980615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiolated glycol chitosan bearing α-cyclodextrin for sustained delivery of PEGylated human growth hormone.
    Sivasubramanian M; Kim YJ; Chae SY; Son S; Jo DG; Lee KC; Yoo CK; Park JH
    J Biomater Sci Polym Ed; 2012; 23(15):1995-2005. PubMed ID: 22040402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys.
    Vugmeyster Y; Seshasayee D; Chang W; Storn A; Howell K; Sa S; Nelson T; Martin F; Grewal I; Gilkerson E; Wu B; Thompson J; Ehrenfels BN; Ren S; Song A; Gelzleichter TR; Danilenko DM
    Am J Pathol; 2006 Feb; 168(2):476-89. PubMed ID: 16436662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR
    Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of ATR-Fc fusion protein in CHO cells].
    Gao LH; Hu XW; Chen W; Xu JJ; Zhao J; Chen HP
    Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):826-31. PubMed ID: 16285529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.